A clinical resource from MindCare Health | Reviewed by Richard Yadon, APRN, PMHNP-BC
You're the one who remembers everyone's appointments, follows up on every loose end, and somehow keeps things together at work even when everything feels like it's about to fall apart.
From the outside, you look capable. Reliable. Like someone who has it figured out.
But on the inside? There's a mental engine that never shuts off. Tasks you meant to do three weeks ago that live in a guilt pile at the back of your brain. Conversations you remember perfectly but actions you can't seem to follow through on. A persistent, low-grade exhaustion from the effort it takes to do things that appear effortless for everyone around you.
Here's what most people don't know: that gap — between how capable you are and how hard everything feels — is often the first sign that something real is going on. Something with a name. Something that has been systematically missed in women for decades.
ADHD in women doesn't look like a hyperactive kid who can't sit still. It looks like you.
Why Do So Many Women Go Undiagnosed With ADHD?
Women with ADHD are underdiagnosed primarily because ADHD research and clinical tools were built around male presentation — specifically, the hyperactive young boy — leaving women's internalized symptoms systematically overlooked. The short answer: the system wasn't built to see them.
For most of ADHD's research history, the condition was studied almost exclusively in young boys with visible, disruptive behavior. The diagnostic tools, the clinical checklists, the training that providers received — all of it was built around a picture that looks nothing like how ADHD presents in most women.
By adulthood, ADHD affects men and women at roughly equal rates (Faraone et al., 2021). The diagnosis gap isn't biology. It's bias baked into a system that spent decades looking in the wrong direction.
According to a 2024 CDC study published in the Morbidity and Mortality Weekly Report (Staley et al.), 61% of women with ADHD received their diagnosis as adults — compared to just 40% of men. Only 25% of women were diagnosed before age 11, versus 45% of men. Those aren't small differences. They represent years — sometimes decades — of struggling without answers.
And things are changing, slowly. According to the American Psychiatric Association, new ADHD diagnoses among adults increased significantly from 2020 to 2023, following years of decline — a trend the APA attributes in part to greater public awareness and reduced stigma (American Psychiatric Association, 2025). More women are being seen. But a significant gap remains.
So what kept them from being seen in the first place?
Women internalize. Boys externalize. Boys with ADHD tend to act out in ways that get them sent to the school counselor. Girls with ADHD tend to turn the disruption inward — anxiety, self-criticism, perfectionism, people-pleasing. They sit quietly and fall apart on the inside. That's not visible in a classroom. It's not what gets a referral.
Add to that a system that was never designed to catch subtle symptoms in high-functioning people, and you get a straightforward explanation for why so many women are still waiting for an answer they should have had years ago.
That's not a personal failure. It's a structural one.
What Does ADHD Actually Look Like in Women?
In women, ADHD most commonly presents as inattention, emotional dysregulation, and exhaustion from years of compensating — not the hyperactivity and impulsivity associated with the condition in boys. Not what you're picturing.
Forget the image of someone who can't sit still, talking over everyone, bouncing from task to task in obvious disarray. That's one version of ADHD — and it's the version that gets caught.
The version that doesn't get caught looks quieter. More internal. Often more organized on the surface, because years of necessity have built elaborate systems to compensate for what the brain doesn't do automatically.
Is It Really Just Anxiety?
ADHD and anxiety frequently co-occur in women and are often confused — but they are clinically distinct conditions that require different treatment approaches. Women with ADHD are frequently diagnosed with anxiety or depression first, sometimes for years, because their internalized symptoms more closely resemble mood disorders than the textbook ADHD presentation.
Emotional dysregulation — difficulty managing the intensity of feelings, not just the presence of them — is one of the most consistent features of ADHD in women. Getting frustrated faster than the situation seems to warrant. Feeling personally stung by neutral feedback. Spending hours recovering from a small setback that others shake off in minutes.
This isn't a character flaw. It's a core feature of how ADHD affects the brain's ability to regulate emotional responses.
Then there's rejection sensitivity — a heightened, sometimes painful reaction to perceived criticism, disapproval, or exclusion. Women with undiagnosed ADHD often describe it as making relationships exhausting. You're not oversensitive. Your nervous system is processing those moments differently.
A large Swedish population-based study (Skoglund et al., Journal of Child Psychology and Psychiatry, 2024) found that women with ADHD have nearly double the rates of anxiety disorders compared to men with ADHD — 50.4% versus 25.9%. And significantly higher rates of self-harm events before diagnosis: 5.0% versus 1.6% in men. These aren't coincidences. They're what happens when a condition goes unidentified for years while a person tries to explain away their own experience.
If you've been managing anxiety for a long time without ever quite getting on top of it, that pattern may be worth exploring with a provider.
What About the High Achievers?
High achievement does not rule out ADHD. Many women with ADHD are high performers who have compensated for executive function difficulties through extraordinary effort — masking symptoms that clinical tools were never designed to catch.
Intelligence masks ADHD. In early school years, raw ability carries a lot of students through. The gaps start showing when external scaffolding disappears — in college, in the years after, when parenting and career demands pile up simultaneously and there's no longer a structured environment doing some of that executive work for you.
Executive function — the mental process responsible for planning, prioritizing, starting tasks, and following through — is where ADHD does its quiet damage. Not IQ. Not ambition. Not work ethic.
You can be genuinely capable and still struggle to start a task you care about. You can have excellent judgment and still lose track of time. You can know exactly what needs to happen and still find yourself doing something else entirely two hours later, unable to explain why.
That's not laziness. That's not a lack of discipline. That's what ADHD looks like when it has never been identified.
Research from Faraone et al. (2021) found that adult ADHD affects approximately 2.8% of adults worldwide — and those are only the ones who have been diagnosed. The actual number is almost certainly higher, given how many women are still waiting for answers they don't yet know to go looking for.
The coping strategies that carried you this far — the color-coded calendars, the running lists, the relentless over-preparation — those aren't evidence against ADHD. In many cases, they're evidence of how hard you've been working to manage something that was never identified.
Why Do Doctors Keep Missing It?
Because the picture they were trained to look for doesn't match the person sitting in front of them.
Most providers who trained before the last decade were taught to screen for ADHD using tools developed and normed on male populations. Those tools ask about disruptive behavior, poor academic performance, and obvious inattention — the kind you can observe in a classroom. They weren't designed to catch a woman who built three organizational systems specifically to prevent herself from losing things. By the time she walks into a clinical setting, her compensatory strategies may make her appear fully functional on a checklist.
The result is a pipeline that looks something like this: anxiety symptoms get treated with an SSRI. Mood dips get treated with therapy. Attention problems get labeled as stress. Each intervention helps a little — because the secondary symptoms are real — but nothing quite sticks, because the underlying ADHD is still there, still untreated, still driving the wheel.
Women with ADHD were diagnosed an average of four years later than men in a study of over 85,000 individuals with ADHD — at age 23.5 versus 19.6 for men (Skoglund et al., Journal of Child Psychology and Psychiatry, 2024). Four years. During which many of those women were likely receiving treatment for the wrong primary diagnosis.
There's also what researchers and clinicians have documented as the "you're too high-functioning" dismissal — the implicit logic that success is evidence against ADHD (Attoe & Climie, 2023). If you graduated. If you have a career. If you're managing. Then surely the problem can't be that significant.
But success in women with ADHD is often the product of extraordinary effort, not the absence of a real condition. The effort is just invisible. And when it becomes unsustainable — when the compensating finally stops working — the collapse can feel sudden to everyone who assumed things were fine.
The American Psychiatric Association reports that in 2010, males were 133% more likely than females to receive an ADHD diagnosis. By 2022, that gap had narrowed to 28% (American Psychiatric Association, 2025). Progress — but a gap that wide narrowing that recently tells you something about how long the clinical picture has lagged behind the reality.
The system is catching up. Many women, though, have been waiting a long time for it.
Does Hormonal Change Make This Worse?
For many women with ADHD, yes — and this connection is one of the least discussed in the conversation about women's health.
Here's the biological connection: estrogen supports dopamine activity — the brain chemical most directly involved in attention, motivation, and executive function. When estrogen is higher, many women with ADHD report that symptoms feel more manageable. When it drops, the opposite happens.
This plays out across a woman's reproductive life in predictable patterns. During the follicular phase of the menstrual cycle — when estrogen is rising — focus and follow-through tend to improve. During the luteal phase — when estrogen drops in the two weeks before a period — many women notice symptoms worsening, sometimes significantly (Faraone et al., 2021). ADHD medications can also become less effective during this phase, which creates a frustrating inconsistency that's easy to misread as the medication not working.
The same dynamic intensifies during major hormonal transitions. Many women describe postpartum as the period when things fell apart in a way they couldn't explain — which makes sense, given that estrogen drops sharply after delivery. Perimenopause, which can begin in the mid-to-late 30s, often marks the point where previously managed symptoms become unmanageable.
A 2025 population-based cohort study found that the difference in perimenopausal symptom severity was most pronounced at ages 35–39 in women with ADHD — suggesting an onset of perimenopause up to 10 years earlier than in the general population (Jakobsdóttir Smári et al., European Psychiatry, 2025). That's not coincidence. That's estrogen declining ahead of schedule, in a brain that was already running closer to its limit.
For women in this age range who are noticing that their focus, organization, or emotional regulation is getting harder to hold together — and who have always suspected something was off but never had answers — perimenopause may be less the cause and more the moment when what was always there finally becomes undeniable.
Perimenopause doesn't create ADHD. It unmasks it.
This is worth raising explicitly with any provider you see for evaluation. Your reproductive history, cycle patterns, and where you are in hormonal transition are all relevant pieces of the picture.
What Happens When ADHD Goes Undiagnosed for Decades?
When ADHD goes undiagnosed in women, the consequences compound across decades — including career underperformance, chronic relationship strain, financial difficulties, and significant damage to self-esteem and identity (Attoe & Climie, 2023).
The most visible costs are functional — underperforming relative to real capability, difficulty sustaining relationships, and chronic disorganization despite genuine effort. These are the practical effects of executive function difficulties that never got the right support.
But the deeper costs are often internal. When ADHD goes unrecognized for years, the person living with it usually fills in the explanation themselves. I'm lazy. I'm flaky. I should be better at this. Everyone else manages to do these things — why can't I?
That internal narrative doesn't stay neutral. It becomes identity. And by the time many women seek evaluation, they're carrying years of accumulated shame for something that was never their fault to begin with.
A 2023 systematic review in the Journal of Attention Disorders (Attoe & Climie) found that women with undiagnosed ADHD experience significant, ongoing harm to self-esteem, social functioning, and psychosocial well-being across their entire lifespan — from childhood through adulthood. Not occasional difficulty. Consistent, measurable, lifelong impact.
The research also shows what changes when women do receive a diagnosis. A 2025 mixed-methods study published in Scientific Reports found that women described receiving an ADHD diagnosis as a turning point — one that allowed their lives to finally make sense, with lasting improvements in self-esteem and how they understood their own history (Holden & Kobayashi-Wood, 2025).
That's not a small thing. Being told there is a name for your experience, that you were not failing, that your brain was working differently than the systems you were placed in — that matters.
Whether you receive an ADHD diagnosis or not, the evaluation process often provides something worth having: a clearer, more accurate picture of how your brain actually works. And that picture changes what's possible.
What Does Getting Evaluated Actually Involve?
An adult ADHD evaluation typically involves a structured clinical interview, developmental history, standardized rating scales, and screening for co-occurring conditions — and can be completed entirely via telehealth.
It's a structured clinical conversation — one that looks at your current functioning, your history, and the patterns that have followed you through school, work, and relationships. The goal isn't to assign a label. It's to understand how your brain processes attention, emotion, and executive function, and what that means for your day-to-day life.
You don't need old report cards, though they can help. You don't need a referral. You don't need to have failed visibly at something before you qualify to ask questions about how your brain works.
For women in Tennessee, access has historically been the biggest barrier — not motivation. Ninety-five percent of Tennessee counties carry mental health care provider shortage designations, with only about 11% of the state's mental health professional need currently being met (Tennessee Department of Mental Health and Substance Abuse Services, 2021). In-person ADHD evaluations can carry wait times measured in months. Transportation is among the most commonly cited barriers to healthcare access across Tennessee's rural communities.
Virtual evaluation changes that math. And it's not a lesser option. The same evidence-based clinical tools and interview process used in person are used via telehealth — the outcomes are the same, and the research supports their validity. According to 2024 CDC data (Staley et al., MMWR), approximately 46% of adults with ADHD have already used telehealth for ADHD services — roughly double the rate among adults without ADHD.
Under current Tennessee telehealth law, a provider-patient relationship can be established entirely through telehealth, with no initial in-person visit required. That means evaluation, diagnosis, and — where clinically appropriate — medication management, all accessible without a referral, a waiting room, or a six-month delay.
If medication is part of the plan, the evidence is clear on what's possible. Clinical research and treatment guidelines consistently report that 60–80% of adults with ADHD see significant symptom improvement with appropriate medication. A meta-analysis from Harvard Medical School (Boland et al., Journal of Psychiatric Research, 2020) found ADHD medication is associated with meaningfully reduced risks for mood disorders, suicidality, substance use, and accidents. Medication isn't the whole picture — but for many people, it levels the playing field in a way that makes everything else more possible.
Frequently Asked Questions
Can I have ADHD if I was never hyperactive?
Yes. Hyperactivity is one presentation of ADHD — not a requirement for diagnosis. Many women have the inattentive subtype, which presents as internal restlessness, difficulty sustaining focus, forgetfulness, and emotional dysregulation rather than visible physical activity (Faraone et al., 2021). If you never fit the "bouncing off the walls" image, that doesn't rule out ADHD. It may simply mean the way ADHD presents in you was overlooked.
Could what I'm experiencing be anxiety instead of ADHD?
It could be either — or both. Anxiety and ADHD frequently co-occur, and many women with ADHD develop anxiety as a secondary condition from years of unmanaged symptoms. The difference matters clinically: treating anxiety without addressing underlying ADHD often brings partial relief at best. A professional evaluation looks at both, considers which came first, and identifies whether attention and executive function difficulties are present independent of anxiety.
Is a virtual ADHD evaluation as thorough as an in-person one?
Yes. Virtual evaluations use the same evidence-based clinical interview process and validated assessment tools as in-person appointments. Research supports their diagnostic accuracy and validity. For most adults, the convenience of telehealth also removes the barriers — scheduling delays, travel time, time away from work — that would otherwise prevent evaluation from happening at all (Staley et al., 2024).
What if I don't have ADHD?
That's still useful information. An evaluation that rules out ADHD often clarifies what else may be affecting your focus, energy, or executive function — whether that's anxiety, sleep disruption, hormonal factors, or something else entirely. Many people leave an evaluation without an ADHD diagnosis and still leave with a clearer picture of how their brain works. Either outcome gives you something real to work with.
Does ADHD get worse during perimenopause?
For many women with ADHD, yes — and this is one of the most underrecognized patterns in women's mental health. Estrogen supports dopamine activity, which directly affects attention regulation. As estrogen declines during perimenopause, symptoms that were previously manageable can become significantly harder to hold together. If you're in your late 30s or 40s and noticing a meaningful shift in focus, emotional regulation, or organizational ability, that timing is clinically relevant and worth discussing with a provider.
If anything in this post felt familiar — the exhaustion of keeping everything together, the anxiety that never quite resolves, the sense that your brain works differently than everyone else's and you've spent years trying to hide it — a professional evaluation can give you real answers.
That's not a small thing. It's the difference between spending another decade explaining yourself to yourself, and finally understanding how your brain actually works.
MindCare Health offers virtual ADHD evaluations for adults across Tennessee. Appointments are private-pay, HSA/FSA eligible, and designed around your schedule — no waiting rooms, no referrals required, no months-long wait.
When you're ready, we're here.
Schedule your evaluation at mindcarehealth.com
This content is for educational purposes only. It is not intended to diagnose, treat, or replace professional medical advice. If you are experiencing mental health symptoms, please consult a licensed provider. Do not stop or adjust medication without medical supervision.
References
American Psychiatric Association. (2025). ADHD in adults: New research highlights trends and challenges. https://www.psychiatry.org/news-room/apa-blogs/adhd-in-adults-new-research-highlights
Attoe, D. E., & Climie, E. A. (2023). Miss. Diagnosis: A systematic review of ADHD in adult women. Journal of Attention Disorders, 27(7), 645–657. https://doi.org/10.1177/10870547231161533
Boland, H., DiSalvo, M., Fried, R., Woodworth, K. Y., Wilens, T., Faraone, S. V., & Biederman, J. (2020). A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. Journal of Psychiatric Research, 123, 21–30. https://doi.org/10.1016/j.jpsychires.2020.01.006
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., … & Wang, Y. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022
Holden, E., & Kobayashi-Wood, H. (2025). Adverse experiences of women with undiagnosed ADHD and the invaluable role of diagnosis. Scientific Reports, 15, Article 20945. https://doi.org/10.1038/s41598-025-04782-y
Jakobsdóttir Smári, U., Valdimarsdottir, U. A., Wynchank, D., de Jong, M., Aspelund, T., Hauksdottir, A., Thordardottir, E. B., Tomasson, G., Jakobsdottir, J., Lu, D., Nevriana, A., Larsson, H., Kooij, S., & Zoega, H. (2025). Perimenopausal symptoms in women with and without ADHD: A population-based cohort study. European Psychiatry, 68(1), e133. https://doi.org/10.1192/j.eurpsy.2025.10101
Paul, M. L., Sheth, P., Davis, R., Chrusciel, T., & Messias, E. (2025). Incidence of attention-deficit/hyperactivity disorder between 2016 and 2023: A retrospective cohort. Psychiatric Research and Clinical Practice. https://doi.org/10.1176/appi.prcp.20240121
Skoglund, C., Sundström Poromaa, I., Leksell, D., Giacobini, M., & Kopp Kallner, H. (2024). Time after time: Failure to identify and support females with ADHD — a Swedish population register study. Journal of Child Psychology and Psychiatry, 65(6), 832–844. https://doi.org/10.1111/jcpp.13920
Staley, B. S., Robinson, L. R., Claussen, A. H., Holbrook, J. R., Charania, S. N., Yamamoto, K., & Danielson, M. L. (2024). Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. Morbidity and Mortality Weekly Report, 73(40), 890–895. https://doi.org/10.15585/mmwr.mm7340a1
Tennessee Department of Mental Health and Substance Abuse Services. (2021). 2021 needs assessment summary. https://www.tn.gov/content/dam/tn/mentalhealth/planning/FINAL%202021%20NA%20Summary.pdf